Daniel J. Levitt, Chief Medical Officer at CYTRX CORP (CYTR), bought 100,000 shares at $0.29 ($29K) on 2012-02-22, disclosed to the SEC on 2012-02-24.
Open-market purchase of $29k CYTR by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.